Short-selling firm Muddy Waters said in a legal filing on Monday that outside experts it hired validated its claims that St. Jude Medical Inc cardiac implants are vulnerable to potentially life-threatening cyber attacks. U.S. regulators responded by ...
Short seller Muddy Waters Capital, which holds a short position in St. Jude Medical Inc., claimed Wednesday for the second time that the medical device maker's implantable cardiac devices are vulnerable to cyberattack.
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the ADO II AS (AMPLATZER™ Duct Occluder II Additional Sizes) pediatric clinical trial.
Commenting on the company's financial results, St. Jude Medical President and Chief Executive Officer Michael T. Rousseau said, “Third quarter results continue to confirm that our innovation based growth strategy is on track.